Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic–severe combined immunodeficient assay
Karen K. Ballen
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorHelen Valinski
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorDale Greiner
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorPamela S. Becker
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorChung Cheng Hsieh
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorF. Marc Stewart
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorPeter J. Quesenberry
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorKaren K. Ballen
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorHelen Valinski
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorDale Greiner
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorPamela S. Becker
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorChung Cheng Hsieh
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorF. Marc Stewart
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorPeter J. Quesenberry
University of Massachusetts Cancer Center, Worcester, MA, and
Search for more papers by this authorAbstract
Umbilical cord blood is an alternative stem cell source for patients without matched family donors. In this study, we examined several parameters that have not been studied in detail – radiation dose, cell dose, age of mice, and maternal and neonatal characteristics of the cord blood donor – that affect engraftment of cord blood in non-obese diabetic–severe combined immunodeficient (NOD–scid) mice. Engraftment, measured using flow cytometry analyses of human CD45+ cells, was highest in 400 cGy-treated mice. Successful engraftment was demonstrated up to 6 months, with a mean engraftment of 31% (range 0–67%) of human cells in recipient bone marrow. Engraftment was skewed to B lymphocytes. The radiation dose of 350 cGy resulted in superior survival of the murine recipients compared with 400 cGy (P = 0.03). The sex of the NOD–scid recipients had a significant effect on survival (female superior to male, P = 0·01), but not on engraftment. There were high levels of variability among different cord units and among animals injected with the same cord unit. This variability may limit the clinical usefulness of the NOD–scid mice as hosts for the quantification of human stem cells.
References
- Armitage, P. & Berry, G. (1994). Statistical Methods in Medical Research. 3rd edn. Blackwell, Boston, MA.
- Ballen, K.K., Becker, P.S., Greiner, D., Valinski, H., Shearin, D., Berrios, V., Dooner, G., Hsieh, C., Wuu, J., Shultz, L., Cerny, J., Leif, J., Stewart, F.M., Quesenberry, P. (2000a) Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD–scid mice. British Journal of Haematology, 108, 629–640.DOI: 10.1046/j.1365-2141.2000.01865.x
- Ballen, K.K., Wilson, M., Valinski, H., Wuu, J., Ceredona, A., Hsieh, C., Stewart, M., Popovsky, M., Quesenberry, P. (2000b) Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplantation, 27, 7–14.
- Berrios, V.M., Dooner, G.J., Ballen, K.K., Becker, P.S. (1999) Modulation of adhesion of CD 34+ cells to extracellular matrix by expansion cytokines: reversible adhesion defect correlates with cell cycle progression. [abstract]. Blood, 94, 43a.
- Bhatia, M., Wang, J.C.Y., Kapp, U., Bonnet, D., Dick, J.E. (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 94, 5320–5325.
- Blundell, M.P., Demaison, C., Brouns, G., Goldman, J.P., Gaspar, H.B., Kinnon, C., Thrasher, A.J., Lazzari, L., Sirchia, G. (1999) Quality of repopulation in nonobese diabetic severe combined immunodeficient mice engrafted with expanded cord blood CD 34+ cells. Blood, 94, 3269–3270.
- Bonnet, D., Bhatia, M., Wang, J.C.Y., Kapp, U., Dick, J.E. (1999) Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplantation, 23, 203–209.
- Cashman, J.D. & Eaves, C.J. (1999) Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice. Blood, 93, 481–487.
- Cashman, J., Bockhold, K., Hogge, D.E., Eaves, A.C., Eaves, C.J. (1997a) Sustained proliferation, multilineage differentiation and maintenance of primitive human haematopoietic cells in NOD–scid mice transplanted with human cord blood. British Journal of Haematology, 98, 1026–1036.
- Cashman, J.D., Lapidot, T., Wang, J.C.Y., Doedens, M., Shultz, L.D., Lansdorp, P., Dick, J.E., Eaves, C.J. (1997b) Kinetic evidence of the regeneration of multilineage hematopiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood, 89, 4307–4316.
- Fraser, J.K., Cairo, M.S., Wagner, E.L., McCurdy, P.R., Baxter-Lowe, L.A., Carter, S.L., Kernan, N.A., Lill, M.C., Slone, V., Wagner, J.E., Wallas, C.H., Kurtzberg, J. (1998) Cord blood transplantation study (COBLT); cord blood bank standard operating procedures. Journal of Hematotherapy, 7, 521–561.
- Gluckman, E., Broxmeyer, H.E., Auerback, A.D., Friedman, H.S., Douglas, G.W., Devergie, A., Esperou, H., Thierry, D., Socia, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J., Boyse, E.A. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine, 321, 1174–1178.
- Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M., Chastang, C. (1997) Outcome of cord blood transplantation from related and unrelated donors. New England Journal of Medicine, 337, 373–381.
- Greiner, D.L., Hesselton, R.A., Shultz, L.D. (1998) SCID mouse models of human stem cell engraftment. Stem Cells, 16, 166–177.
- Guenechea, G., Segovia, J.C., Albella, B., Lamana, M., Ramirez, M., Regidor, C., Fernandez, M.N., Bueren, J.A. (1999) Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34+ cord blood cells. Blood, 93, 1097–1059.
- Hogan, C.J., Shpall, E., McNulty, O., McNiece, I., Dick, J.E., Shultz, L.D., Keller, G.I. (1997) Engraftment and development of human CD34+ enriched cells from umbilical cord blood in NOD/LtSz-Scid mice. Blood, 90, 85–96.
- Holyoke, T.L., Nicolini, F.E., Eaves, C.J. (1999) Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Experimental Hematology, 27, 1418–1427.DOI: 10.1016/s0301-472x(99)00078-8
- Kapp, U., Bhatia, M., Bonnet, D., Murdoch, B., Dick, J.E. (1998) Treatment of non-obese diabetic (NOD)/severe-combined immunodeficient mice (SCID) with flt3ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells. Blood, 92, 2024–2031.
- Kogler, G., Callejas, J., Hakenberg, P., Enczmann, J., Adams, D., Daubener, W., Krempe, C., Gobel, U., Somville, T., Wernet, P. (1996) Hematopoietic transplant potential of unrelated cord blood: critical issues. Journal of Hematotherapy, 5, 105–116.
- Kurtzberg, J., Laughlin, M., Graham, M.L., Smith, C., Olson, J.F., Halperin, E.C., Ciocci, G., Carrier, C., Stevens, C.E., Rubinstein, P. (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New England Journal of Medicine, 335, 157–166.
- Lang, P., Schumm, M., Taylor, G., Klingebiel, T., Neu, S., Geiselhart, A., Kuci, S., Niethammer, D., Handgretinger, R. (1999) Clinical scale isolation of highly purified peripheral CD 34+ progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplantation, 24, 583–589.
- Leung, W., Ramirez, M., Civin, C.I. (1999) Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. Biology of Blood and Marrow Transplantation, 5, 69–76.
- Link, H., Arseniev, L., Bahre, O., Kadar, J.G., Diedrich, H., Poliwoda, H. (1996) Transplantation of allogeneic CD 34 blood cells. Blood, 87, 4903–4909.
- Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., Messina, C., Ortega, J., Badell-Serra, I., Plouvier, E., Souillet, G., Jouet, J.P., Pasquini, R., Ferreira, E., Garnier, F., Gluckman, E. (1999) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood, 93, 3662–3671.
- Lowry, P.A., Shultz, L.D., Greiner, D.L., Hesselton, R.M., Kittler, E.L.W., Tiarks, C.Y., Rao, S.S., Leif, J.H., Ramshaw, H.S., Quesenberry, P.J. (1996) Improved engraftment of human stem cells in NOD LtSz scid/scid mice after radiation and multiple day injections. Biology of Blood and Marrow Transplantation, 2, 15–23.
- McNiece, I.K., Stoney, G.B., Kern, B.P., Bridell, R.A. (1998) CD4+cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices. Journal of Hematotherapy, 7, 457–461.
- Nicolini, F.E., Holyoake, T.L., Cashman, J.D., Chu, P.P., Lambie, K., Eaves, C.J. (1999) Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice. Blood, 94, 2686–2695.
- Noort, W.A., Willemze, R., Falkenburg, J.H.F. (1998) Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice. Bone Marrow Transplantation, 22, S58–S60.
- Peters, S.O., Kittler, E.L., Lu, E., Ramshaw, H.S., Quesenberry, P.J. (1996) Ex vivo expansion of murine marrow cells with interleukin-3, interleukin-6, interleukin-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood, 87, 30–37.
- Piacibello, W., Sanavio, F., Severino, A., Dane, A., Gammaitoni, L., Fagioli, F., Perissinotto, E., Cavalloni, G., Kollet, O., Lapidot, T., Aglietta, M. (1999) Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD 34+ cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood, 93, 3736–3749.
- Querol, S., Gabarro, M., Amat, L., Gonzalez, S., Gomez, M.D., De La Calle, O., Madoz, P., Badell, I., Garcia, J. (1998) The placental blood program of the Barcelona Cord Blood Bank. Bone Marrow Transplantation, 22, S3–S5.
- Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.I., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E., Stevens, C.E. (1998) Outcomes among 562 recipients of placental blood transplants from unrelated donors. New England Journal of Medicine, 339, 1565–1577.
- SAS Institute (1990) SAS/STAT User's Guide, Vol 2, GLM-VARCOMP, Version 6 4th edn. SAS Institute, Cary, NC.
- Verstegen, M.M.A., Van Hennik, P., Terpstra, W., Van Den Bos, C., Wielenga, J.J., Van Rooijen, N., Ploemacher, R.E., Wagemaker, G., Wognum, A.W. (1998) Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD 34+ CD 38- cells. Blood, 91, 1966–1976.
- Vormoor, J., Lapidot, T., Pflumio, F., Risdon, G., Patterson, B., Broxmeyer, H.E., Dick, J.E. (1994) Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood, 83, 2489–2497.
- Wang, J.C.Y., Doedens, M., Dick, J.E. (1997) Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood, 89, 3919–3924.
- Wyrsch, A., Carbonare, V., Jansen, W., Chklovskaia, E., Nissen, C., Surbek, D., Holzgreve, W., Tichelli, A., Wodnar-Filipowicz, A. (1999) Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Experimental Hematology, 27, 1338–1345.DOI: 10.1016/s0301-472x(99)00059-4